Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings' Operating Expenses history spans 5 years, with the latest figure at $101419.0 for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 18.71% to $101419.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $496214.0, a 19.26% decrease, with the full-year FY2025 number at $684281.0, down 0.74% from a year prior.
  • Operating Expenses hit $101419.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $138643.0 in the prior quarter.
  • Over the last five years, Operating Expenses for CBIH hit a ceiling of $311998.0 in Q1 2023 and a floor of $90841.0 in Q3 2025.
  • Historically, Operating Expenses has averaged $182552.0 across 5 years, with a median of $154239.5 in 2023.
  • Biggest five-year swings in Operating Expenses: crashed 68.68% in 2024 and later skyrocketed 72.89% in 2025.
  • Tracing CBIH's Operating Expenses over 5 years: stood at $259099.0 in 2022, then tumbled by 44.74% to $143168.0 in 2023, then dropped by 11.94% to $126072.0 in 2024, then grew by 9.97% to $138643.0 in 2025, then decreased by 26.85% to $101419.0 in 2026.
  • Business Quant data shows Operating Expenses for CBIH at $101419.0 in Q1 2026, $138643.0 in Q4 2025, and $90841.0 in Q3 2025.